CN109609661A - A kind of combination of kidney-yang deficiency exogenous disease mouse model lung tissue qPCR reference gene and its screening technique - Google Patents

A kind of combination of kidney-yang deficiency exogenous disease mouse model lung tissue qPCR reference gene and its screening technique Download PDF

Info

Publication number
CN109609661A
CN109609661A CN201811620437.XA CN201811620437A CN109609661A CN 109609661 A CN109609661 A CN 109609661A CN 201811620437 A CN201811620437 A CN 201811620437A CN 109609661 A CN109609661 A CN 109609661A
Authority
CN
China
Prior art keywords
gene
kidney
yang deficiency
combination
reference gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201811620437.XA
Other languages
Chinese (zh)
Other versions
CN109609661B (en
Inventor
杨勇
容蓉
付业佩
杨佳
范珊珊
赵绍哲
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shandong University of Traditional Chinese Medicine
Original Assignee
Shandong University of Traditional Chinese Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shandong University of Traditional Chinese Medicine filed Critical Shandong University of Traditional Chinese Medicine
Priority to CN201811620437.XA priority Critical patent/CN109609661B/en
Publication of CN109609661A publication Critical patent/CN109609661A/en
Application granted granted Critical
Publication of CN109609661B publication Critical patent/CN109609661B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/686Polymerase chain reaction [PCR]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/166Oligonucleotides used as internal standards, controls or normalisation probes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The present invention relates to Protocols in Molecular Biology, in particular to a kind of reference gene combination and its screening technique based on qPCR technology.A kind of screening technique of kidney-yang deficiency exogenous disease mouse model lung tissue qPCR reference gene combination, design 15 reference gene Actb, β 2m, Gapdh, Gusb, Tuba, Grcc10, Eif4h, Rnf187, Nedd8, Ywhea, 18S rRNA, RPL13, Ubc, RPL32, the specific primer of Ppia, upstream and downstream primer sequence is successively as shown in SEQ ID NO.3-32, then using kidney-yang deficiency exogenous disease mouse model cDNA as template, it is utilized respectively the specific primer and RT-qPCR analysis is carried out to 15 reference genes, in conjunction with the absolute value of average value compares between t inspection and group between group, in the convenient and efficient establishment kidney-yang deficiency exogenous disease mouse model lung tissue qPCR of energy The ginseng assortment of genes is Grcc10 and Ppia.Present invention firstly discovers that being combined into Grcc10 and Ppia for kidney-yang deficiency exogenous disease most suitable qPCR reference gene group.It lays the foundation for the subsequent development list of target genes expression study on the disease binding model.

Description

A kind of combination of kidney-yang deficiency exogenous disease mouse model lung tissue qPCR reference gene and its screening Method
Technical field
The present invention relates to Protocols in Molecular Biology, in particular to a kind of reference gene combination and its sieve based on qPCR technology Choosing method.
Background technique
Real-Time Fluorescent Quantitative PCR Technique (quantitative real-time PCR, qPCR) is a kind of real-time monitoring Pcr amplification product and the quantitative approach parsed, have sensibility it is high, it is reproducible, detection speed fastly, high degree of automation Many advantages, such as, it is widely applied by domestic and foreign scholars at present.The technology is generally required with the stable reference gene of expression to target The expression of gene is corrected and standardizes.Ideal reference gene should under a variety of experimental conditions, and various types of groups Knit with expression constant in cell, and its expression quantity be it is approximate, there was no significant difference.However, different types of tissue, no Reference gene transcriptional level may change under the conditions of the same stage of development and different disposal, therefore, select in suitable Ginseng gene determines to reduce the difference between detection sample and utilizes the reliable of quantitative fluorescent PCR analysis gene expression dose result Property.
Previous research is mostly with the numerous reference gene of expression quantity such as rRNA 18S rRNA or 28S rRNA, 3- phosphorus Acid glycerol dehydrogenase and actin etc. are used as internal reference.However, a large amount of studies have shown that these common reference genes are not It is also changed with the expression under experiment condition.There are severe deviations in the result that the use of unstable reference gene will lead to qPCR. Much studies have shown that an extensive general reference gene is not present, researcher needs in each experiment or species The suitable gene for stablizing expression is found as internal reference.In Bestkeeper, geNorm and NormFinder etc. are widely used as Join genescreen software, researcher can be helped to select stable reference gene, but these software screening methods in different research To single internal reference or double reference genes be unsuitable for the reference gene for kidney-yang deficiency exogenous disease lung tissue.In recent years, document It is more common in yulan[8], rhizoma alismatis[9], teasel[10]The report of the RT-qPCR reference gene screening of equal medicinal plants is more and more, but It there is no the report about the screening of kidney-yang deficiency exogenous disease mouse model lung tissue RT-qPCR reference gene at present.
Summary of the invention
Goal of the invention of the invention is the t method of inspection between the group for introducing statistical analysis, can efficiently and accurately screen conjunction Suitable double reference genes combination can be used for research of the subsequent development to kidney-yang deficiency exogenous disease lung tissue destination gene expression.
For achieving the above object, using following technical scheme:
A kind of kidney-yang deficiency exogenous disease mouse model lung tissue qPCR reference gene combination, which is characterized in that the reference gene combination For Grcc10 and Ppia.
The screening technique of above-mentioned kidney-yang deficiency exogenous disease mouse model lung tissue qPCR reference gene combination, separately designs first 15 reference gene Actb, β 2m, Gapdh, Gusb, Tuba, Grcc10, Eif4h, Rnf187, Nedd8, Ywhea, 18S The specific primer of rRNA, RPL13, Ubc, RPL32, Ppia, upstream and downstream primer sequence successively as shown in SEQ ID NO.3-32, Then with kidney-yang deficiency exogenous disease mouse model, cDNA is template, is utilized respectively the specific primer and carries out to 15 reference genes The kidney-yang deficiency exogenous disease mouse model lung tissue qPCR reference gene combination is established in RT-qPCR analysis.
Preferably, screening technique the following steps are included:
(1) kidney-yang deficiency model is replicated;
(2) kidney-yang deficiency exogenous disease model is established;
(3) RT- PCR detects the expression of the mRNA of H1N1 in lung tissue;
(4) total RNA from animal tissues is extracted;
(5) reverse transcription synthesizes cDNA;
(6) design amplimer carries out RT- PCR amplification;15 reference genes Actb, β 2m, Gapdh, Gusb are separately designed, Tuba, Grcc10, Eif4h, Rnf187, Nedd8, Ywhea, 18S rRNA, RPL13, Ubc, RPL32, Ppia, the internal reference base The specific primer sequence of cause is successively as shown in SEQ ID NO.1-30;
(7) the RT-PCR analysis of reference gene;Using the method for dual-gene combination of two, and to the dual-gene just of combination of two Gene expression difference between normal group and model group carries out T inspection, selects combined P value to be greater than 0.05 or more, and carried out this For the normal group combined a bit compared with the absolute value of model group difference, the smallest combination of absolute value for screening difference refers to base as double The optimal combination of cause, analyze Grcc10+Ppia combination gene be kidney-yang deficiency exogenous disease mouse model stabilization reference gene.
Preferably, the method that kidney-yang deficiency model is replicated described in step (1) is that 2mg/mL benzene first is injected intraperitoneally with 4mL/kg Sour estradiol dilution, one time a day, continuous 7d replicates kidney-yang deficiency model.
Preferably, the method that kidney-yang deficiency exogenous disease model is established described in step (1) is to give postanesthetic mice with kidney-yang deficiency Collunarium is inoculated with 20 μ L/ of influenza virus H1N1 chick embryo allantoic liquid only, normal to organize the isometric physiological saline of collunarium, virus inoculation Mouse isolation is fed, and ad lib 6 d of water inlet, dissection is put to death;Wherein the tissue culture infective dose of chick embryo allantoic liquid is TCID50 2.34×108
Preferably, RT-PCR amplification program described in step (6) are as follows: 1 circulation, 95 DEG C of 10s are carried out under 95 DEG C of 15min 40 circulations are carried out with 60 DEG C of 32s.
Preferably, the specific steps of the RT-PCR analysis of reference gene described in step (8) are as follows: (1) 15 reference gene Primer PCR amplification;The expression of (2) 15 reference genes determines;(3) BestKeeper, geNorm and NormFinder are soft Part is to 15 reference gene stability expression analysis of kidney-yang deficiency exogenous disease model;(4) 15 reference gene combination of two T are examined;(5) The verifying of reference gene stability;(6) the stabilization internal reference base that Grcc10+Ppia combination gene is kidney-yang deficiency exogenous disease mouse model is obtained Cause.
Be preferably, TLR3, TLR4 for target gene selected by the verifying of reference gene stability described in step (5), TLE7,RIG-1;The primer sequence of target gene is successively as shown in SEQ ID NO.31-38.
The present invention refers to gene and double reference assortments of genes in the expression of target gene in the list that software is calculated It is upper with we filtered out it is double there is different with reference to genes, or even occur on the contrary as a result, therefore BestKeeper, The optimal reference gene and double genes that refer to that the softwares such as geNorm and NormFinder calculate can not be used as most stable of reference Gene.This research examines the dual-gene combination for filtering out P > 0.05 in double screening processes with reference to gene by T first, On the basis of this, the absolute value with model group difference is further normally organized relatively after combination of two, is made with the smallest absolute value of difference For the optimum combination of reference gene two-by-two.Show the importance of reference gene selection by the verifying of target gene.
This research has selected 15 common reference genes: gene enrich cluster C10 gene (gene rich cluster, C10 gene, Grcc10), beta-actin (beta-actin, Actb), glycerol-3-phosphate (glyceraldehyde-3-phosphate dehydrogenase, gapdh), eukaryotic translation initiation factor 4H The expression development of (eukaryotic translation initiation factor 4H, Eif4h), neural precursor is lowered Gene 8 (neural precursor cell expressed developmentally down-regulated gene 8, Nedd8), ring finger protein 187 (ring finger protein 187, Rnf187), tyrosine 3-monooxygenase/tryptophan 5- monooxygenase activator protein ε peptide (tyrosine3-monooxygenase/tryptophan 5-monooxygenase Activation protein, epsilon, Ywhae), beta-glucuronic acid (beta-glucuronidase, Gusb), Alpha-tubulin (alpha-tubulin, Tuba), beta-2 microglobulin (beta-2 microglobulin, β 2m), 18S core Sugared body RNA (18S ribosomal RNA, 18SrRNA), ribosomal protein L 13 (Ribosomal protein L-13, RPL13), ubiquitin C (Ubiquitin C, Ubc), ribosomal protein L 32 (Ribosomal protein L32, RPL32), Peptide acyl prolyl isomerase A (peptide acyl preserved ammonia acyl isomerase A, Ppia).It sees Expression variation of these genes during kidney-yang deficiency exogenous disease (influenza virus H1N1) is examined, screening is suitable for the stabilization in this stage The reference gene of expression.
Beneficial effect
Present invention firstly discovers that being combined into Grcc10 and Ppia for kidney-yang deficiency exogenous disease most suitable qPCR reference gene group.
Invention introduces the t methods of inspection between the group of statistical analysis, carry out combination of two to 15 kinds of candidate reference genes, And group difference statistics is carried out to double expressions with reference to gene after combination, it is suitable efficiently and accurately to screen Double reference gene combinations finally obtain Grcc10+Ppia combination gene in the normal group of difference minimum between model group, can be used as The stabilization reference gene of kidney-yang deficiency exogenous disease mouse model is the subsequent development list of target genes table on the disease binding model It lays the foundation up to research.
Detailed description of the invention
Fig. 1 is normal group and model group body weight anus temperature, organ index and virus load;
Fig. 2 is 15 expressions with reference to gene in kidney-yang deficiency exogenous disease model;
Fig. 3 is BestKeeper, geNorm and NormFinder to 15 in the kidney-yang deficiency exogenous disease model stability with reference to gene Expression analysis;
Fig. 4 is the relative expression quantity of target gene TLR3, TLR4, TLE7, RIG-1.
Specific embodiment
The principle of the invention and feature are described with reference to the accompanying drawing, illustrated embodiment is served only for explaining the present invention, and Non-limiting the scope of the present invention.
Embodiment 1
1 materials and methods
1.1 animal
SPF grades of Balb/c male mices, body weight 18-20 g, purchase please experimental animal from Jinan friend and breed Co., Ltd, license Card number: the Shandong SCXK() 20140007.
1.2 reagent
Oestradiol benzoate (lot number: 140627, be purchased from the second hormone of Ningbo factory, 2 mg/mL), H1N1 influenza virus (Beijing Square strain is quoted from the Chinese institute of viruses CDC), 0.9% sodium chloride injection (Cisen Pharmaceutical Co., Ltd., lot number: 1601042161), RNAstore sample saves liquid-DP408, total RNA from animal tissues extracts kit-DP431(RNAprep Pure Tissue Kit), cDNA reverse transcription reagent box-KR106, SYBR Green PCR kit for fluorescence quantitative-FP205(days Root company).
1.3 instrument
Quawell ultramicron ultraviolet specrophotometer (USA), fluorescence quantitative PCR instrument (CFX Connect Real-Time System, Bole), anus temperature tester: BAT-12 miniature probe thermometer (U.S. Physitemp Instruments, BAT-12), Toy Anesthesia machine (MIDMARK company, the U.S., model: VMR).
1.4 primer
15 candidate reference genes have been selected in this experiment.Candidate gene is Actb, β 2m, Gapdh, Gusb, Tuba, Grcc10, Eif4h, Rnf187, Nedd8, Ywhea, 18S rRNA, RPL13, Ubc, RPL32, Ppia.Use NCBI BLAST(http: // Blast.ncbi.nlm.nih.gov/Blast.cgi) the nucleotide sequence design primer identified, upstream and downstream primer sequence is successively As shown in SEQ ID NO.3-32;Primer is purchased from Beijing six directions Hua Da Technology Co., Ltd., is shown in Table 1.
2 experimental methods
2.1 animal packet
20 Balb/c mouse are randomly divided into 2 groups according to weight, anus temperature, normal group, model group.
2.2 modeling
2.2.1 kidney-yang deficiency model is replicated
The identical nature and flavor difference channel tropism Chinese medicine of bibliography causes the method in the influence of mice with kidney-yang deficiency with 4mL/kg abdomen to estradiol Chamber injects 2mg/mL oestradiol benzoate dilution, and one time a day, continuous 7d replicates kidney-yang deficiency model, measures autonomic activities, anus Temperature, swimming time, with this decision model success or not.
2.2.2 kidney-yang deficiency exogenous disease model is established
Reference literature kidney-yang deficiency exogenous disease Establishment of mouse model and method in Ephedra asarum monkshood soup intervention study simultaneously change virus Collunarium dosage, give postanesthetic mice with kidney-yang deficiency collunarium inoculation influenza virus H1N1 chick embryo allantoic liquid (TCID50 2.34 × 108) 20 μ L/ only, normal to organize the isometric physiological saline of collunarium, the mouse of virus inoculation, which is isolated, to be fed, ad lib water inlet 6 D, dissection are put to death.
2.3 index determining
2.3.1 each group mouse weight, anus temperature detector survey weight, the anus temperature of daily measurement mouse.
2.3.2 organ index
Lung tissue, heart, liver are taken after dissection, kidney, for calculating organ index, is weighed with weighing after normal saline flushing Tissue samples afterwards immerse RNAstore with 1:10 ratio.
2.4 Real Time PCR detect the expression of the mRNA of H1N1 in lung tissue
2.4.1 Total RNAs extraction
10-20 mg tissue is weighed, extracts its total serum IgE by total RNA from animal tissues extracts kit method.Pass through Quawell ultra micro The yield and purity for measuring ultraviolet specrophotometer measurement RNA use the sample of dulling luminosity ratio OD 260/280 between 1.8 and 2.1 In further analysis.
2.4.2 reverse transcription synthesizes cDNA.
According to cDNA Reverse Transcription cassette method, using 20 42 DEG C of μ L Transcription Systems, 3min removes contaminating genomic DNA, will Total serum IgE and reverse transcriptase FastQuant RT Enzyme, 42 DEG C, 15min synthesizes the first chain cDNA.CDNA is stored in -20 DEG C It is spare.
2.4.3 Real-time PCR
For each reaction, 20 μ L mixtures contain 2 μ L cDNA, and forward and reverse primer sequence is successively such as SEQ ID NO.1- Shown in 30, each 6 pmol, 10 μ L 2 × SuperReal PreMix Plus(Green containing SYBR I).Amplification program is as follows: 1 circulation is carried out under 95 DEG C of 15min, 95 DEG C of 10s and 60 DEG C of 32s carry out 40 circulations.After amplification, heat denatured is obtained The melting curve of PCR product is to verify specific amplification.
Using standard curve calculate each primer pair exponential phase qPCR efficiency (cDNA of reverse transcription carry out 4 times it is continuous dilute Release), average threshold circulation (Ct) value of each serial dilution maps to logarithm.According to equation E=10(-1/slope) × 100 calculate cDNA dilution gfactor, and wherein slope is the gradient of linear regression line.
2.4.4 H1N1 Viral Quantification
H1N1 influenza virus M gene is detected using the Real-Time PCR of SYBR Green dye method.H1N1 influenza virus overall length M gene standard curve use based on primer (F:5 '-CTGAGAAGCAGATACTGGGC-3 ', R:5 '- CTGCATTGTCTCCGAAGAAAT-3 ') Real-Time PCR amplification.PCR product is cloned into pTarget plasmid, uses MEGAshortscript kit is for being transcribed in vitro.The absolute copy number of H1N1 influenza virus M gene passes through standard curve meter It calculates.
2.5 verifying primers
Based on being used in conjunction with as endogenous control gene in previous research, 15 candidate reference genes, candidate base have been selected Because being Actb, β 2m, Gapdh, Gusb, Tuba, Grcc10, Eif4h, Rnf187, Nedd8, Ywhea, 18S rRNA respectively, RPL13, Ubc, RPL32 and Ppia.
It is as follows for verifying the selected primer with reference to gene: TLR3-F:CAGGATACTTCTCGCCTT and TLR3-R: TGGCCGCTGAGTTTGTTTTC;TLR4-F:CATGGATCAGAAACTCAGCAAAGTC and TLR4-R: CATGCCATGCCTTGTCTTCA;TLR7-F:CTGGAGTTCAGCAACCATT and TLR7-R: GTTATCACCGCTCCGCTCCATAGAA;RIG-1-F:GCAGGGGGGGGGGGTTACTGTGGACTTTGTG and RIG-1-R: TGCCATCTCTCCTTTGTGTCT。
The analysis of 2.7 data
These data are used to assess ginseng by three common statistics programs (i.e. geNorm, NormFinder and BestKeeper) Examine the stability of gene.According to formula: 2−ΔCtCt value is converted to nonstandardized technique relative quantity by (Ct=corresponding Ct value-minimum Ct). The relative quantity that the calculating of geNorm and NormFinder is converted based on these;Original Ct value is directly divided by BestKeeper software Analysis.
2.8 statistical analysis
T is examined carrying out group to experimental data using 22.0 software of SPSS, *P< 0.05 and * * P< 0.01 thinks there is system Meter learns meaning.
3 results
3.1 weight, anus temperature, organ index and virus load
Normal group mouse fur is dry and comfortable smooth, and the state of mind is good, and active active, weight is cumulative.Model group mouse infection H1N1 virus for 24 hours after, symptom initial stage be torpescence, scratch nose, apathetic, the symptoms such as hunchbacked atrophy, weight with normal group Mouse, which is compared, significant difference, and anus temperature is significantly lower than normal group mouse (Fig. 1 a, b).Model Lung Exponent significantly increases, seminal vesicle Gland index is substantially reduced (Fig. 1 c), while the absolute copy number of M gene 6.1 of the influenza virus H1N1 of the lung tissue of model mice × 106/ ml or more shows kidney-yang deficiency exogenous disease model construction success (Fig. 1 d).
3.2 refer to gene primer PCR amplification efficiency and specificity
Production 15 standard curves with reference to gene after qRT-PCR reaction, the results show that each coefficient R20.990 is all larger than, 15 pairs of amplification efficiencies referring to gene (table 1) between 91%-98.9%.The above results show respectively with reference to gene primer specificity Meet qRT-PCR requirement, can be used for the estimation of stability with reference to gene.
1 qPCR primer of table and gene sequence information
The expression of 3.3 candidate reference genes
Ct value of 15 candidate reference genes in kidney-yang deficiency exogenous disease model mice is between 13.861-23.572, average value It is 18.591.Wherein Actb expression highest, Ct value is minimum, is 13.861.The expression of Gusb is minimum, and Ct value is maximum, For 23.572(Fig. 2 a).Relative quantification is carried out after the normalized processing of Ct value of 15 candidate genes, uses t test statistics respectively Analyze each candidate reference gene in the normal group of significant difference between model group.The result shows that in this 15 candidates Joining gene relative expression quantity all has significant difference (P < 0.05, or P < 0.01) (Fig. 2 b) between model group at normal group.
Stability of 3.4 BestKeeper, geNorm and NormFinder softwares to kidney-yang deficiency exogenous disease model reference gene Expression analysis
As seen from the figure, the difference that these three common reference gene screening softwares are obtained is expressed not with reference to the stability of gene Unanimously, it can find that the stability of Nedd8 gene is best, and the stability of β 2m gene is worst through the analysis of BestKeeper software; GeNorm software analysis finds that the stability of Ywhea and Tuba gene is best, and the stability of β 2m gene is worst; NormFinder software analysis finds that the stability of 18SrRNA gene is best, and the stability of β 2m gene is worst (Fig. 3).Separately Outside, optimal double reference genes that NormFinder software is analyzed are Eif4h+RPL32(table 2).
2 Normfinder calculated result of table
3.5 examine with reference to gene combination of two T
Using the method for dual-gene combination of two, and to the dual-gene gene table at normal group between model group of combination of two T inspection is carried out up to difference, has the P value of 15 kinds of combinations to be greater than 0.05 or more, does not have the discrepant assortment of genes two-by-two again between these groups The normal group of each combination is carried out compared with the absolute value of model group difference, it is believed that with the smallest group of the absolute value of difference It closes and can be used as double optimal combinations with reference to gene.Experimental result shows that Grcc10+Ppia two refers to the difference of the assortment of genes Minimum (0.009), therefore Grcc10+Ppia combination can be used as the optimal selection (table of kidney-yang deficiency exogenous disease lung tissue sample internal reference 3, table 4).
The T of 3 15 kinds of reference gene combination of two of table examines (P value)
15 kinds of reference gene combination of two T that table 4 filters out examine the difference of P value and average value
3.6 verify with reference to gene stability
In order to verify double stability and reliability with reference to gene, we have selected 4 verifying genes to analyze the phase of target gene To expression: toll sample receptor 3 (TLR3), toll sample receptor 4 (TLR4), toll sample receptor 7 (TLR7) and cytosol view Yellow acid induced gene -1 (RIG-1).As a result, it has been found that selecting double with reference to gene Grcc10+Ppia and Eif4h+RPL32 and not Gene (Nedd8, Ywhea, 18s rRNA) is referred in target gene TLR3, TLR7, RIG-1 with stable list is showed in software Occur certain difference on expression, and in the expression of TLR4 gene, Eif4h+RPL32 combined reference gene and There is opposite result on expression in 18s rRNA (see Fig. 4).
In molecular biology research, gene expression analysis is one of research most common strategy of gene.QRT-PCR because Its expression that Relative gene is widely used in accuracy.In this technique, select to stablize the gene expressed as reference Gene is vital.Cell, tissue or other stress handle after can be expressed with constant level, and have and target The comparable expression of gene.The study find that it is different using the optimal reference gene that different software for calculation obtain, and In kidney-yang deficiency exogenous disease mouse model, using a kind of expression that can not accurately determine target gene with reference to gene, therefore to 15 kinds Candidate reference gene carries out combination of two, and carries out group difference system to double expressions with reference to gene after combination Meter finally obtains Grcc10+Ppia combination gene in the normal group of difference minimum between model group.By verifying target gene TLR3, TLR4, TLR7 and RIG-1 show that the list that software is calculated refers to gene and double reference assortments of genes in target gene Expression on we filtered out it is double there is different with reference to genes, or even occur opposite as a result, therefore The optimal reference gene and double reference genes that the softwares such as BestKeeper, geNorm and NormFinder calculate can not be as most Stable reference gene.This research filters out the biradical of P > 0.05 by T inspection first in double screening processes with reference to gene Because of combination, on this basis, the absolute value with model group difference is further normally organized relatively after combination of two, it is the smallest with difference Optimum combination of the absolute value as reference gene two-by-two.Show the importance of reference gene selection by the verifying of target gene. The study find that Grcc10+Ppia combination gene can be used as the stabilization reference gene of kidney-yang deficiency exogenous disease mouse model, be subsequent Development list of target genes expression study on the disease binding model lays the foundation.
Sequence table
<110>Shandong Traditional Chinese Medicine University
<120>a kind of kidney-yang deficiency exogenous disease mouse model lung tissue qPCR reference gene combination and its screening technique
<160>38
<210>1
<211>23
<212>DNA
<213>artificial sequence
CCTTCTTGGG TATGGAATCC TGT 23
<210>2
<211>26
<212>DNA
<213>artificial sequence
CACTGTGTTG GCATAGAGGT CTTTAC 26
<210>3
<211>18
<212>DNA
<213>artificial sequence
CATGGCTCGC TCGGTGAC 18
<210>4
<211>22
<212>DNA
<213>artificial sequence
CAGTTCAGTA TGTTCGGCTT CC 22
<210>5
<211>19
<212>DNA
<213>artificial sequence
TGCACCACCA ACTGCTTAG 19
<210>6
<211>19
<212>DNA
<213>artificial sequence
GGATGCAGGG ATGATGTTC 19
<210>7
<211>19
<212>DNA
<213>artificial sequence
CCGACCTCTC GAACAACCG 19
<210>8
<211>21
<212>DNA
<213>artificial sequence
GCTTCCCGTT CATACCACAC C 21
<210>9
<211>19
<212>DNA
<213>artificial sequence
TGTCCTGGAC AGGATTCGC 19
<210>10
<211>19
<212>DNA
<213>artificial sequence
CTCCATCAGC AGGGAGGTG 19
<210>11
<211>18
<212>DNA
<213>artificial sequence
GCGGAGGTGA TTCAAGCG 18
<210>12
<211>18
<212>DNA
<213>artificial sequence
TGACCAGGCG GGCAAACT 18
<210>13
<211>18
<212>DNA
<213>artificial sequence
CCTTGGCTCG GGATTGTC 18
<210>14
<211>20
<212>DNA
<213>artificial sequence
TCCGCATTGG AGATGGATTA 20
<210>15
<211>18
<212>DNA
<213>artificial sequence
CTGGCACCAC CCTTCATC 18
<210>16
<211>18
<212>DNA
<213>artificial sequence
ACAAGCCCGA GCACATTC 18
<210>17
<211>20
<212>DNA
<213>artificial sequence
TGGGAAGGAG ATTGAGATAG 20
<210>18
<211>19
<212>DNA
<213>artificial sequence
TTGCTTGCCA CTGTAGATG 19
<210>19
<211>18
<212>DNA
<213>artificial sequence
CCCATTCGTT TAGGTCTT 18
<210>20
<211>18
<212>DNA
<213>artificial sequence
TCCACAGCGT CAGGTTAT 18
<210>21
<211>21
<212>DNA
<213>artificial sequence
TTGACGGAAG GGCACCACCA G 21
<210>22
<211>21
<212>DNA
<213>artificial sequence
GCACCACCAC CCACGGAATC G 21
<210>23
<211>20
<212>DNA
<213>artificial sequence
GTACGCTGTG AAGGCATCAA 20
<210>24
<211>20
<212>DNA
<213>artificial sequence
ATCCCATCCA ACACCTTGAG 20
<210>25
<211>20
<212>DNA
<213>artificial sequence
GCCCAGTGTT ACCACCAAGA 20
<210>26
<211>20
<212>DNA
<213>artificial sequence
CCCATCACAC CCAAGAACA 19
<210>27
<211>17
<212>DNA
<213>artificial sequence
GAACTGGCGG AAACCCA 17
<210>28
<211>20
<212>DNA
<213>artificial sequence
GGATCTGGCC CTTGAACCTT 20
<210>29
<211>20
<212>DNA
<213>artificial sequence
CGCTTGCTGC AGCCATGGTC 20
<210>30
<211>20
<212>DNA
<213>artificial sequence
CAGCTCGAAG GAGACGCGGC 20
<210>31
<211>18
<212>DNA
<213>artificial sequence
CAGGATACTT CTCGCCTT 18
<210>32
<211>20
<212>DNA
<213>artificial sequence
TGGCCGCTGA GTTTGTTTTC 20
<210>33
<211>25
<212>DNA
<213>artificial sequence
CATGGATCAG AAACTCAGCA AAGTC 25
<210>34
<211>20
<212>DNA
<213>artificial sequence
CATGCCATGC CTTGTCTTCA 20
<210>35
<211>19
<212>DNA
<213>artificial sequence
CTGGAGTTCA GCAACCATT 19
<210>36
<211>25
<212>DNA
<213>artificial sequence
GTTATCACCG CTCCGCTCCA TAGAA 25
<210>37
<211>31
<212>DNA
<213>artificial sequence
GCAGGGGGGG GGGGTTACTG TGGACTTTGT G 31
<210>38
<211>19
<212>DNA
<213>artificial sequence
TGCCATCTCT CCTTTGTGTC T 21

Claims (8)

1. a kind of kidney-yang deficiency exogenous disease mouse model lung tissue qPCR reference gene combination, which is characterized in that the reference gene group It is combined into Grcc10 and Ppia.
2. a kind of screening technique of kidney-yang deficiency exogenous disease mouse model lung tissue qPCR reference gene combination described in claim 1, It is characterized in that, 15 reference genes Actb, β 2m, Gapdh, Gusb, Tuba, Grcc10, Eif4h are separately designed first, The specific primer of Rnf187, Nedd8, Ywhea, 18S rRNA, RPL13, Ubc, RPL32, Ppia, upstream and downstream primer sequence according to Secondary, then with kidney-yang deficiency exogenous disease mouse model, cDNA is template as shown in SEQ ID NO.1-30, is utilized respectively the specificity 15 reference genes of primer pair carry out RT-qPCR analysis, establish the kidney-yang deficiency exogenous disease mouse model lung tissue qPCR internal reference base Because of combination.
3. screening technique according to claim 2, which comprises the following steps:
(1) kidney-yang deficiency model is replicated;
(2) kidney-yang deficiency exogenous disease model is established;
(3) RT- PCR detects the expression of the mRNA of H1N1 in lung tissue;
(4) total RNA from animal tissues is extracted;
(5) reverse transcription synthesizes cDNA;
(6) design amplimer carries out RT- PCR amplification;15 reference genes Actb, β 2m, Gapdh, Gusb are separately designed, Tuba, Grcc10, Eif4h, Rnf187, Nedd8, Ywhea, 18S rRNA, RPL13, Ubc, RPL32, Ppia, the internal reference base The specific primer sequence of cause is successively as shown in SEQ ID NO.1-30;
(7) the RT-PCR analysis of reference gene;Using the method for dual-gene combination of two, and to the dual-gene just of combination of two Gene expression difference between normal group and model group carries out T inspection, selects combined P value to be greater than 0.05 or more, and carried out this For the normal group combined a bit compared with the absolute value of model group difference, the smallest combination of absolute value for screening difference can be used as double references The optimal combination of gene, analyze Grcc10+Ppia combination gene be kidney-yang deficiency exogenous disease mouse model stabilization reference gene.
4. screening technique according to claim 3, which is characterized in that replicate the side of kidney-yang deficiency model described in step (1) Method is that 2mg/mL oestradiol benzoate dilution is injected intraperitoneally with 4mL/kg, and one time a day, continuous 7d replicates kidney-yang deficiency model.
5. screening technique according to claim 3, which is characterized in that establish kidney-yang deficiency exogenous disease model described in step (1) Method be to give postanesthetic mice with kidney-yang deficiency collunarium to be inoculated with 20 μ L/ of influenza virus H1N1 chick embryo allantoic liquid only, normal group drop The isometric physiological saline of nose, the mouse of virus inoculation, which is isolated, to be fed, and ad lib 6 d of water inlet, dissection is put to death;Wherein chicken embryo is urinated The tissue culture infective dose of cyst fluid is TCID50 2.34 × 108
6. screening technique according to claim 3, which is characterized in that RT- PCR amplification program described in step (6) are as follows: 1 circulation is carried out under 95 DEG C of 15min, 95 DEG C of 10s and 60 DEG C of 32s carry out 40 circulations.
7. according to screening technique as claimed in claim 3, which is characterized in that the RT-PCR of reference gene described in step (8) is analyzed Specific steps are as follows: the amplification of (1) 15 reference gene primer PCR;The expression of (2) 15 reference genes determines;(3) BestKeeper, geNorm and NormFinder software are to 15 reference gene stability expression analysis of kidney-yang deficiency exogenous disease model; (4) 15 reference gene combination of two T are examined;(5) reference gene stability is verified;(6) obtaining Grcc10+Ppia combination gene is The stabilization reference gene of kidney-yang deficiency exogenous disease mouse model.
8. screening technique according to claim 7, which is characterized in that be used for reference gene stability described in step (5) The selected target gene of verifying is TLR3, TLR4, TLE7, RIG-1;The primer sequence of target gene is successively such as SEQ ID Shown in NO.31-38.
CN201811620437.XA 2018-12-28 2018-12-28 Kidney yang deficiency exogenous mouse model lung tissue qPCR (quantitative polymerase chain reaction) reference gene combination and screening method thereof Active CN109609661B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811620437.XA CN109609661B (en) 2018-12-28 2018-12-28 Kidney yang deficiency exogenous mouse model lung tissue qPCR (quantitative polymerase chain reaction) reference gene combination and screening method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811620437.XA CN109609661B (en) 2018-12-28 2018-12-28 Kidney yang deficiency exogenous mouse model lung tissue qPCR (quantitative polymerase chain reaction) reference gene combination and screening method thereof

Publications (2)

Publication Number Publication Date
CN109609661A true CN109609661A (en) 2019-04-12
CN109609661B CN109609661B (en) 2022-06-24

Family

ID=66012258

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811620437.XA Active CN109609661B (en) 2018-12-28 2018-12-28 Kidney yang deficiency exogenous mouse model lung tissue qPCR (quantitative polymerase chain reaction) reference gene combination and screening method thereof

Country Status (1)

Country Link
CN (1) CN109609661B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113284610A (en) * 2021-05-12 2021-08-20 哈尔滨医科大学 Method for detecting composite biomarker of advanced gastric cancer

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013102680A1 (en) * 2012-01-05 2013-07-11 Centre National De La Recherche Scientifique (Cnrs) Signature for the diagnosis of lung cancer aggressiveness and genetic instability
WO2013104131A1 (en) * 2012-01-13 2013-07-18 北京命码生科科技有限公司 Standardized reference gene for microrna and use thereof
WO2016205911A1 (en) * 2015-06-23 2016-12-29 Fundação Antonio Prudente In vitro method for detecting thyroid cancer in a patient, in vitro method for differentiating between thyroid cancer and normal thyroid tissue or benign thyroid lesions, use of a series of genes, method for obtaining data determining the treatment of thyroid cancer, laboratory kit and device for classifying a biological sample from the thyroid gland as malignant or benign
CN106591477A (en) * 2017-01-24 2017-04-26 中国农业科学院兰州畜牧与兽药研究所 Method of using multiple reference gene combinations to study yak embryo gene
CN107308168A (en) * 2017-06-19 2017-11-03 中国农业大学 A kind of medicine for suppressing the intracellular duplication of porcine reproductive and respiratory syndrome virus
CN107858438A (en) * 2017-10-12 2018-03-30 华南农业大学 The reference gene combination and its application of harmonia axyridia stable expression under the different factors

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013102680A1 (en) * 2012-01-05 2013-07-11 Centre National De La Recherche Scientifique (Cnrs) Signature for the diagnosis of lung cancer aggressiveness and genetic instability
WO2013104131A1 (en) * 2012-01-13 2013-07-18 北京命码生科科技有限公司 Standardized reference gene for microrna and use thereof
WO2016205911A1 (en) * 2015-06-23 2016-12-29 Fundação Antonio Prudente In vitro method for detecting thyroid cancer in a patient, in vitro method for differentiating between thyroid cancer and normal thyroid tissue or benign thyroid lesions, use of a series of genes, method for obtaining data determining the treatment of thyroid cancer, laboratory kit and device for classifying a biological sample from the thyroid gland as malignant or benign
CN106591477A (en) * 2017-01-24 2017-04-26 中国农业科学院兰州畜牧与兽药研究所 Method of using multiple reference gene combinations to study yak embryo gene
CN107308168A (en) * 2017-06-19 2017-11-03 中国农业大学 A kind of medicine for suppressing the intracellular duplication of porcine reproductive and respiratory syndrome virus
CN107858438A (en) * 2017-10-12 2018-03-30 华南农业大学 The reference gene combination and its application of harmonia axyridia stable expression under the different factors

Non-Patent Citations (11)

* Cited by examiner, † Cited by third party
Title
TOSHIFUMI YOKOYAMA ET AL: "Identification of reference genes for quantitative PCR analyses in developing mouse gonads", 《J VET MED SCI》 *
ZHIQIANG PAN ET AL: "Osthole, a coumadin analog from Cnidium monnieri (L.) Cusson, stimulates corticosterone secretion by increasing steroidogenicenzyme expression in mouse Y1 adrenocortical tumor cells", 《JOURNAL OF ETHNOPHARMACOLOGY》 *
吴巧等: "H5N1 禽流感病毒感染小鼠后内参基因的筛选", 《中国畜牧兽医》 *
尹翠翠 等: "肾阳虚外感小鼠模型的建立及评价", 《中国实验方剂学杂志》 *
曾瀞瑶: "基于小鼠15个组织RNA-seq数据的全基因组重注释", 《中国博士学位论文全文数据库 基础科学辑》 *
李力,廖明主编: "《实用生物医学概论教程》", 31 July 2016, 广西科学技术出版社 *
杨勇: "肾阳虚外感小鼠模型建立及麻黄细辛附子汤干预研究", 《中国博士学位论文全文数据库 医药卫生科技辑》 *
聂培婷等: "冷诱导RNA结合蛋白参与小鼠H1N1甲型流感病毒感染的应答", 《畜牧兽医学报》 *
莫俊銮 等: "硒干预和DNCB致敏实验小鼠的基因表达分析参考基因的筛选", 《中国热带医学》 *
董恩妮等: "实时荧光定量PCR内参基因的选择", 《中国畜牧杂志》 *
董晓丽 等: "幼龄小鼠小肠组织内参基因的选择", 《甘肃农业大学学报》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113284610A (en) * 2021-05-12 2021-08-20 哈尔滨医科大学 Method for detecting composite biomarker of advanced gastric cancer

Also Published As

Publication number Publication date
CN109609661B (en) 2022-06-24

Similar Documents

Publication Publication Date Title
CN107058623B (en) High-sensitivity and specific blood HBV pgRNA fluorescent quantitative PCR detection system and detection method
CN109576352A (en) Single tube detects method, probe and its kit of multiple object to be measured nucleic acid sequences
CN107488711B (en) Method for detecting genotype of point mutation and kit thereof
CN114085903B (en) Primer pair probe combination product for detecting mitochondria 3243A &amp; gtG mutation, kit and detection method thereof
CN113337639B (en) Method for detecting COVID-19 based on mNGS and application thereof
CN111534637B (en) Universal primer, probe and kit for enterovirus nucleic acid detection
CN106755571A (en) It is a kind of for detecting zika virus, dengue fever virus and the kit of CHIK
CN108192965B (en) Method for detecting heterogeneity of mitochondrial genome A3243G locus
CN112301129A (en) BCR-ABL fusion gene detection kit and BCR-ABL fusion gene detection method
CN106811517A (en) It is a kind of for detecting that c-MET gene extrons 14 are skipped the composition and kit of mutation
CN111304365A (en) Novel one-step loop-mediated isothermal detection reagent for gosling gout virus and application thereof
CN110724767A (en) Triple real-time fluorescent quantitative PCR (polymerase chain reaction) primer, probe and kit for detecting dengue fever, chikungunya and Zika viruses
CN112322789B (en) Nested PCR (polymerase chain reaction) kit and method for detecting double RNA (ribonucleic acid) viruses of micropterus salmoides
CN109762932A (en) Identify the detection primer and probe, kit and application of HP-PRRSV and NADC30-like strain
CN109609661A (en) A kind of combination of kidney-yang deficiency exogenous disease mouse model lung tissue qPCR reference gene and its screening technique
CN112301168A (en) TaqMan real-time fluorescent quantitative RT-PCR kit and method for detecting double RNA viruses of micropterus salmoides
CN116356054A (en) Kit for detecting common pathogenic microorganisms and drug resistance genes and detection method
CN110724763A (en) Fluorescent quantitative PCR detection method for human adenovirus and bocavirus and application thereof
CN113817870B (en) Primer composition for simultaneously detecting seven respiratory tract related viruses and application thereof
CN108531598A (en) ROS1 Gene Fusions detection primer, method and kit
CN112725534B (en) Primer probe, target combination, kit and method for detecting karya virus, hazara virus and epstein-barr virus
CN114410795A (en) Liver cancer early detection based on miRNA (micro ribonucleic acid) feature marker
CN109777888A (en) Primer combination that is a kind of while detecting a variety of A group Human enterovirus virus and its application
CN108330213B (en) Method for simultaneously carrying out HBV DNA quantification, genotyping and RT region mutation detection
CN108728528B (en) Fluorescent quantitative PCR one-step kit for detecting specific gene of renal tubular epithelial cell based on Taqman probe

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant